We are live on
!
Find out more
NanoViricides
NNVC
NNVC
30 hedge funds and large institutions have $1.51M invested in NanoViricides in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
192% more call options, than puts
Call options by funds: $312K | Put options by funds: $107K
0.23% more ownership
Funds ownership: 11.52% → 11.75% (+0.23%)
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
3% less funds holding
Funds holding: 31 → 30 (-1)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
34% less capital invested
Capital invested by funds: $2.3M → $1.51M (-$787K)
Holders
30
Holders Change
-1
Holders Change %
-3.23%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
8
Reduced
8
Closed
6
Calls
$312K
Puts
$107K
Net Calls
+$205K
Net Calls Change
-$185K
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$81.6K |
| 2 |
Millennium Management
New York
|
+$39K |
| 3 |
VF
Virtu Financial
New York
|
+$18.1K |
| 4 |
Renaissance Technologies
New York
|
+$9.21K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.58K |
